Evidence map›Paper›PMID 34079799›Full record

ReviewFrontiers in cell and developmental biology2021

Hippo Signaling Pathway in Pancreas Development.

Yifan Wu, Pauline Aegerter, Michael Nipper, Logan Ramjit, Jun Liu, Pei Wang

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in cell and developmental biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Cancer Stem Cells in Pancreatic Ductal Adenocarcinoma.International journal of molecular sciences · 2023
    Review
  11. TAZ promotes PDX1-mediated insulinogenesis.Cellular and molecular life sciences : CMLS · 2022
    Article
  12. Review
  13. Apoptosis in Type 2 Diabetes: Can It Be Prevented? Hippo Pathway Prospects.International journal of molecular sciences · 2022
    Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Yifan WuDepartment of Cell Systems and Anatomy, The University of Texas Health San Antonio, San Antonio, TX, United States.
Pauline AegerterDepartment of Cell Systems and Anatomy, The University of Texas Health San Antonio, San Antonio, TX, United States.
Michael NipperDepartment of Cell Systems and Anatomy, The University of Texas Health San Antonio, San Antonio, TX, United States.
Logan RamjitDepartment of Cell Systems and Anatomy, The University of Texas Health San Antonio, San Antonio, TX, United States.
Jun LiuDepartment of Cell Systems and Anatomy, The University of Texas Health San Antonio, San Antonio, TX, United States.
Pei WangDepartment of Cell Systems and Anatomy, The University of Texas Health San Antonio, San Antonio, TX, United States.
The University of Texas Health Science Center at San Antonio · USSecond Xiangya Hospital of Central South University · CN

Funding

Mechanisms of pancreatic cancer initiation and progression from normal human pancreatic tissueR01CA237159 · NCI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI WANG, PEI · 2020 to 2025
$1.7M
The Hippo signaling pathway in pancreatic epithelial cells orchestrate the inflammatory response R01R01DK110361 · NIDDK · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI WANG, PEI · 2017 to 2021
$1.7M
NCI NIH HHS R01 CA237159NIDDK NIH HHS R01 DK110361
6 · The paper itself

Abstract

The Hippo signaling pathway is a vital regulator of pancreatic development and homeostasis, directing cell fate decisions, morphogenesis, and adult pancreatic cellular plasticity. Through loss-of-function research, Hippo signaling has been found to play key roles in maintaining the proper balance between progenitor cell renewal, proliferation, and differentiation in pancreatic organogenesis. Other studies suggest that overactivation of YAP, a downstream effector of the pathway, promotes ductal cell development and suppresses endocrine cell fate specification via repression of Ngn3. After birth, disruptions in Hippo signaling have been found to lead to de-differentiation of acinar cells and pancreatitis-like phenotype. Further, Hippo signaling directs pancreatic morphogenesis by ensuring proper cell polarization and branching. Despite these findings, the mechanisms through which Hippo governs cell differentiation and pancreatic architecture are yet to be fully understood. Here, we review recent studies of Hippo functions in pancreatic development, including its crosstalk with NOTCH, WNT/β-catenin, and PI3K/Akt/mTOR signaling pathways.

Indexed as

developmentHippoLATS1/2Mst1/2pancreasYAP

Identifiers

PMID34079799
PMCPMC8165189
OpenAlexW3162618737

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.